PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator. - Wikidata - wikimedia - TriplyDB

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

http://www.wikidata.org/entity/Q34305022

about

Positron emission tomography to assess hypoxia and perfusion in lung cancer PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.Pilot Study of 64Cu(I) for PET Imaging of Melanoma Thermal dose fractionation affects tumour physiological response The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Development of copper based drugs, radiopharmaceuticals and medical materials.Copper-64 Radiopharmaceuticals for Oncologic Imaging A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.Radiocopper for the imaging of copper metabolism.Molecular imaging of hypoxia in non-small-cell lung cancer.Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.Towards new horizons in brain PET.Clinical PET imaging of tumour hypoxia in lung cancer

P2860

Q27026940-3F52C697-CD9A-4DB9-8007-E785588CC88B Q33715458-CDA2270E-4234-4FD0-9DC9-C01F8ACB8EA5 Q33746948-E84053BA-0559-4987-A536-39B2A5ACAADA Q34340122-ADA58C58-2568-4A0C-AC6D-6E8067402C57 Q35111985-FF20650C-6270-4656-88E8-675D2805ABBB Q35565683-E389BE07-494E-443F-A541-630BD616DF4C Q36394415-C6E03FCB-941A-408E-A8A0-4F8469DDFC35 Q37126530-9172C555-4BA4-4C33-9A31-E41F1CB41548 Q37172093-5F8474A3-E9A3-4A17-BFDE-A4BAC6EDA312 Q37298667-DE36F113-9B02-4175-A069-239BEF555191 Q37506093-7FF52C6D-5E2E-410D-BAAB-1F21346123B7 Q37702961-2434435D-8E8D-4952-AFFC-31ACA90B4129 Q38196380-76A6DEC7-B1FE-4AFE-95C3-9412A502C59B Q38363234-25025CD9-E1B8-455D-AE50-2CB86EB209ED Q46454434-977779F4-285D-4BBE-B8AB-E44741E5B805 Q53227485-225FDFD2-8885-42FB-8D1A-149F03599B4C Q57780509-74627429-418D-4E0D-B3F9-CD59535432D8

P2860

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

http://www.wikidata.org/entity/Q34305022

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@ast

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@en

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@nl

type

label

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@ast

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@en

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@nl

prefLabel

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@ast

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@en

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@nl

P1433

Q34305022-4FD87642-E0B7-4F95-8039-D697B289E016

P1476

Q34305022-FD938BE4-55CC-4973-9877-1F33F61BC3BE

P2093

Q34305022-0CC594B8-F743-4DF7-89DF-7D86932FF8A2

Q34305022-122B20CD-E693-45D3-B790-2EED053C0843

Q34305022-3AF2FCED-A8D7-495A-826F-6954C3CB7284

Q34305022-D35E3EB8-B6BA-4318-B98E-6902ADCF128A

Q34305022-DBE0E94B-7D4D-4D65-81BB-46A4BD199ACB

Q34305022-E2AA4450-B5A5-4CB9-A788-F7295DAB6442

Q34305022-F6E4D79A-52F9-4F16-9F6B-28AAB753B224

P2860

Q34305022-09B6C23C-BB8E-444B-9C1B-13DC684AC87F

Q34305022-3FD56907-B9F1-4F32-B60E-976BB2EAF36B

Q34305022-424D6263-411E-49C4-833A-C7785EC6C37C

Q34305022-4D2D676D-CE92-4EA5-B477-D80CF02A4CAA

Q34305022-53015BE9-537E-4D14-9933-04535A9463B9

Q34305022-71D71FE3-5408-42CB-986E-043DF0CF44DD

Q34305022-82F68524-FFDF-4E9F-80EF-AC59F3DF9B9D

Q34305022-8C198CCC-BCC2-4BAC-AA9F-BB5D565F71AC

Q34305022-AA44E687-A68C-4466-AE7F-8DB78EF16654

Q34305022-D17176F7-32D7-4F77-8971-83D704ED08F4

P304

Q34305022-02FD4E42-6DDE-4032-9931-D2D983DA815C

P31

Q34305022-7237C802-98AF-451E-BEB3-7663DDF12B67

P356

Q34305022-FA860049-2B04-4316-A3F8-43202057C607

P407

Q34305022-7C9E01CA-6249-4D21-9D12-AF27F6721BD5

P433

Q34305022-944ECFAC-5DEE-499A-95CF-385B4E25EE8E

P478

Q34305022-231FE66C-E399-49A2-975D-520EA217C001

P577

Q34305022-51AB47BC-9E8D-45C3-9C3A-A37A71DA5DDE

P698

Q34305022-A4FD20D1-34D7-4306-92C8-231236774925

P921

Q34305022-04F44E40-E1C8-412B-82E7-227D81DD32B9

P932

Q34305022-1BF87E4C-994A-43D7-A6F6-9074753248BB

P356

P1433

American Journal of Roentgenology

P1476

PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

@en

P2093

Gordana Vlahovic

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Lacy

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Neil A Petry

http://www.w3.org/2001/XMLSchema#string

Terence Z Wong

http://www.w3.org/2001/XMLSchema#string

Thomas A Sporn

http://www.w3.org/2001/XMLSchema#string

Thomas C Hawk

http://www.w3.org/2001/XMLSchema#string

P2860

Copper-62-pyruvaldehyde bis(N-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans.

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.

Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.

Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.

P304

427-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2214/AJR.07.2876

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18212229

http://www.w3.org/2001/XMLSchema#string

P921

P932

2980329

http://www.w3.org/2001/XMLSchema#string